Literature DB >> 24237182

Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury.

Sarah A Figley1, Ramak Khosravi, Jean M Legasto, Yun-Fan Tseng, Michael G Fehlings.   

Abstract

Significant vascular changes occur subsequent to spinal cord injury (SCI), which contribute to progressive pathophysiology. In the present study, we used female Wistar rats (300-350 g) and a 35-g clip-compression injury at T6 to T7 to characterize the spatial and temporal vascular changes that ensue post-SCI. Before sacrifice, animals were injected with vascular tracing dyes (2% Evans Blue (EB) or fluorescein isothiocyanate/Lycopersicon esculentum agglutinin [FITC-LEA]) to assess blood-spinal cord barrier (BSCB) integrity or vascular architecture, respectively. Spectrophotometry of EB tissue showed maximal BSCB disruption at 24 h postinjury, with significant disruption observed until 5 days postinjury (p<0.01). FITC-LEA-identified functional vasculature was dramatically reduced by 24 h. Similarly, RECA-1 immunohistochemistry showed a significant decrease in the number of vessels at 24 h postinjury, compared to uninjured animals (p<0.01), with slight increases in endogenous revascularization by 10 days postinjury. White versus gray matter (GM) quantification showed that GM vessels are more susceptible to SCI. Finally, we observed an endogenous angiogenic response between 3 and 7 days postinjury: maximal endothelial cell proliferation was observed at day 5. These data indicate that BSCB disruption and endogenous revascularization occur at specific time points after injury, which may be important for developing effective therapeutic interventions for SCI.

Entities:  

Mesh:

Year:  2014        PMID: 24237182      PMCID: PMC3949504          DOI: 10.1089/neu.2013.3034

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  36 in total

Review 1.  Postnatal vasculogenesis.

Authors:  D Ribatti; A Vacca; B Nico; L Roncali; F Dammacco
Journal:  Mech Dev       Date:  2001-02       Impact factor: 1.882

Review 2.  A monitored contusion model of spinal cord injury in the rat.

Authors:  J A Gruner
Journal:  J Neurotrauma       Date:  1992       Impact factor: 5.269

3.  Neuronal and glial apoptosis after traumatic spinal cord injury.

Authors:  X Z Liu; X M Xu; R Hu; C Du; S X Zhang; J W McDonald; H X Dong; Y J Wu; G S Fan; M F Jacquin; C Y Hsu; D W Choi
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

4.  Vascular mechanisms in the pathophysiology of human spinal cord injury.

Authors:  C H Tator; I Koyanagi
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

5.  Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury.

Authors:  J Lou; L G Lenke; F J Ludwig; M F O'Brien
Journal:  Spinal Cord       Date:  1998-10       Impact factor: 2.772

6.  Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.

Authors:  Toshiaki Aoki; Toshihisa Sumii; Tatsuro Mori; Xiaoying Wang; Eng H Lo
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

7.  The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat.

Authors:  L J Noble; J R Wrathall
Journal:  Brain Res       Date:  1987-10-20       Impact factor: 3.252

8.  Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury.

Authors:  P A Schumacher; J H Eubanks; M G Fehlings
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

9.  Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury.

Authors:  Tomoyuki Yoshihara; Masayoshi Ohta; Yutaka Itokazu; Naoya Matsumoto; Mari Dezawa; Yoshihisa Suzuki; Akihiko Taguchi; Yumi Watanabe; Yasushi Adachi; Susumu Ikehara; Hisashi Sugimoto; Chizuka Ide
Journal:  J Neurotrauma       Date:  2007-06       Impact factor: 5.269

10.  Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle.

Authors:  Britta Engelhardt; Caroline Coisne
Journal:  Fluids Barriers CNS       Date:  2011-01-18
View more
  69 in total

1.  Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury.

Authors:  Yue Gao; Sivakumar Vijayaraghavalu; Melinda Stees; Brian K Kwon; Vinod Labhasetwar
Journal:  J Control Release       Date:  2019-03-28       Impact factor: 9.776

2.  Combining Bone Marrow Stromal Cells with Green Tea Polyphenols Attenuates the Blood-Spinal Cord Barrier Permeability in Rats with Compression Spinal Cord Injury.

Authors:  De-shui Yu; Li-bo Liu; Yang Cao; Yan-song Wang; Yun-long Bi; Zi-Jian Wei; Song-ming Tong; Gang Lv; Xi-fan Mei
Journal:  J Mol Neurosci       Date:  2015-05-26       Impact factor: 3.444

Review 3.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

4.  Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord Injury.

Authors:  Kimberly M Anderson; C Jane Welsh; Colin Young; Gwendolyn J Levine; Sharon C Kerwin; C Elizabeth Boudreau; Ismael Reyes; Armando Mondragon; John F Griffin; Noah D Cohen; Jonathan M Levine
Journal:  J Neurotrauma       Date:  2015-07-17       Impact factor: 5.269

5.  Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury.

Authors:  Anna Badner; Reaz Vawda; Alex Laliberte; James Hong; Mirriam Mikhail; Alejandro Jose; Rachel Dragas; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

6.  5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Kristan H Cleveland; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2019-11-27       Impact factor: 4.030

7.  Exosome-mediated inflammasome signaling after central nervous system injury.

Authors:  Juan Pablo de Rivero Vaccari; Frank Brand; Stephanie Adamczak; Stephanie W Lee; Jon Perez-Barcena; Michael Y Wang; M Ross Bullock; W Dalton Dietrich; Robert W Keane
Journal:  J Neurochem       Date:  2015-03-01       Impact factor: 5.372

8.  Neural stem cell-derived exosomes facilitate spinal cord functional recovery after injury by promoting angiogenesis.

Authors:  Dong Zhong; Yong Cao; Cheng-Jun Li; Miao Li; Zi-Jie Rong; Liyuan Jiang; Zhu Guo; Hong-Bin Lu; Jian-Zhong Hu
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-05

9.  Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats.

Authors:  Yilin Mao; Tara Nguyen; Ryan S Tonkin; Justin G Lees; Caitlyn Warren; Simon J O'Carroll; Louise F B Nicholson; Colin R Green; Gila Moalem-Taylor; Catherine A Gorrie
Journal:  Exp Brain Res       Date:  2017-07-19       Impact factor: 1.972

Review 10.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.